Publications by authors named "Ginevra Moschione"
Article Synopsis
- * This case report introduces the use of semaglutide, a GLP-1 receptor agonist, for managing hypothalamic obesity following surgery for craniopharyngioma.
- * The 18-year-old patient experienced remarkable weight loss of over 30 kg in just six months, marking a significant breakthrough in the treatment of hypothalamic obesity.
Introduction: Proteinuria is a major risk factor for the progression of chronic kidney disease (CKD). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) demonstrated a nephroprotective and antiproteinuric effect in people with type 2 diabetes (T2DM) and proteinuric CKD. We conducted a retrospective study to evaluate clinical and laboratory variables that can help predict proteinuria reduction with SGLT2i therapy.
View Article and Find Full Text PDF